Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension-Reference-Cited by-同舟云学术

Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension

Published:2005-04 Issue:4 Volume:27 Page:441-450
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

PARK S,CHUNG N,KWON J,YOON J,KIM Y,HAN D,KIM H

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study;Drug Design, Development and Therapy;2018-12

2. Comparative Effect of Racemic Amlodipine and its Enantiomer with Atenolol on Hypertensive Patients—A Randomized, Open, Parallel Group Study;Journal of Experimental & Clinical Medicine;2013-12

3. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms;Current Medical Research and Opinion;2009-07-14

4. Blood pressure responder rates versus goal rates: which metric matters?;Therapeutic Advances in Cardiovascular Disease;2009-01-26

5. Improved Stability against Moisture of Amlodipine Maleate Tablets using Microcrystalline Cellulose and Pregelatinized Starch;Journal of Korean Pharmaceutical Sciences;2008-06-20